Cyclerion Therapeutics Inc (CYCN) stock news · rev $2.1M
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
This CYCN news page leads with what Cyclerion Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CYCN yet. We will not pad this page with generic market recap.
Latest reported CYCN revenue for 2025-12-31 was $2.1M. Net income was -$3.5M. Revenue was up 3.7% from 2024-12-31 to 2025-12-31. CYCN currently screens at market cap $8.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CYCN stock page; for the tape open the quote page.
CYCN stock news FAQ
What are CYCN's latest revenue and net income?
Latest cached Cyclerion Therapeutics Inc (CYCN) revenue for Dec 31, 2025 was $2.1M. Net income was -$3.5M. Statements: https://lician.com/financials/cycn
How did CYCN revenue change from the prior cached period?
Cached Cyclerion Therapeutics Inc (CYCN) revenue was up 3.7% from $2.0M (Dec 31, 2024) to $2.1M (Dec 31, 2025). Statements: https://lician.com/financials/cycn
What is CYCN's market cap?
Cyclerion Therapeutics Inc (CYCN) market cap is $8.6M on the latest cached fundamentals snapshot.
What kind of company is CYCN?
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
Where is CYCN stock news listed?
Cached stock news for Cyclerion Therapeutics Inc (CYCN) is listed at https://lician.com/news/cycn. Filings: https://lician.com/sec/cycn
Not investment advice.